Effectiveness of Acupuncture for Anxiety Among Patients With Parkinson Disease: A Randomized Clinical Trial

Fan et al. · JAMA Network Open · 2022

🔬Double-Blind RCT👥n=64 participantsHigh Impact - JAMA

Evidence Level

STRONG
85/ 100
Quality
5/5
Sample
3/5
Replication
4/5
🎯

OBJECTIVE

To investigate the effectiveness of acupuncture versus sham acupuncture for the treatment of anxiety in patients with Parkinson disease

👥

WHO

64 patients with Parkinson disease and anxiety, mean age 61.8 years, in China

⏱️

DURATION

8 weeks of treatment with 8 weeks of follow-up

📍

POINTS

GV-24, GV-29, HT-7 bilateral, SP-6 bilateral, and SiShenZhen 四神针 (4 scalp points)

🔬 Study Design

64participants
randomization

Real Acupuncture + Clinical Monitoring

n=32

True acupuncture 3x/week for 8 weeks

Sham Acupuncture + Clinical Monitoring

n=32

Placebo acupuncture 3x/week for 8 weeks

⏱️ Duration: 8 weeks of treatment + 8 weeks of follow-up

📊 Results in numbers

0.22-point difference

Reduction in anxiety (HAM-A) at end of treatment

7.03-point greater reduction

Reduction in anxiety (HAM-A) at 2 months

86.8% vs 6.4%

Patients with clinically meaningful improvement at follow-up

4 mild reactions

Adverse events

Percentage highlights

86.8% vs 6.4%
Patients with clinically meaningful improvement at follow-up

📊 Outcome Comparison

HAM-A Anxiety Scale (follow-up)

Real Acupuncture
10.97
Sham Acupuncture
18.56

UPDRS I - Mental Aspects (follow-up)

Real Acupuncture
2.06
Sham Acupuncture
5.28
💬 What does this mean for you?

This study shows that acupuncture may be an effective option for reducing anxiety in people with Parkinson disease. Although both groups improved initially, only patients who received true acupuncture maintained the benefits after treatment ended, with significant reduction in anxiety and improved quality of life.

📝

Article summary

Plain-language narrative summary

Anxiety is one of the most common manifestations in patients with Parkinson disease, affecting approximately 31% of these individuals. Although it is a frequent and debilitating symptom, anxiety in Parkinson disease often remains inadequately treated. This condition is closely related to accelerated progression of motor symptoms, including worsening of tremor and gait disturbances. Patients with Parkinson disease who also experience anxiety show greater disability and poorer quality of life compared with those without anxiety.

The conventional treatments available, such as antiparkinsonian drugs and anxiolytics, offer limited clinical benefit, while psychological therapies such as cognitive behavioral therapy, although promising, have a high cost that reduces patient adherence.

This study aimed to investigate the efficacy of true acupuncture versus sham (placebo) acupuncture for the treatment of anxiety in patients with Parkinson disease. It was a randomized, double-blind clinical trial conducted at a hospital in China between June 2021 and April 2022. Seventy eligible patients were enrolled and randomly divided into two groups: one received true acupuncture and the other sham acupuncture. The researchers developed a specialized sham-needle device to ensure that neither patients nor acupuncturists knew which treatment was being administered.

Treatment consisted of 30-minute sessions, three times per week for eight weeks, using specific acupuncture points traditionally used for anxiety and Parkinson disease. Follow-up of patients continued for an additional eight weeks after treatment ended.

The results revealed important findings about the effects of acupuncture on Parkinson-related anxiety. Sixty-four patients completed the study, with a mean age of approximately 62 years. At the end of the eight-week treatment period, both groups showed significant improvement in anxiety as measured by the Hamilton Anxiety Rating Scale, with no statistical difference between them. This suggests there was a substantial initial placebo effect.

However, two months after treatment ended, the group that received true acupuncture maintained the improvement, showing a 7.03-point reduction on the anxiety scale compared with the placebo group. In addition, the true acupuncture group also showed better outcomes on scales evaluating Parkinson motor symptoms and quality of life. Blood tests revealed that acupuncture reduced levels of the hormone ACTH, which is related to stress and anxiety, providing a biological basis to explain the observed effects.

For patients with Parkinson disease and anxiety, these results suggest that acupuncture may be a valuable and safe therapeutic option. The study demonstrated that, although there may be an initial placebo effect, the benefits of true acupuncture become clearly superior over the long term. During the study, only four mild adverse reactions were reported, indicating that the treatment is well tolerated. For health care professionals, these findings indicate that acupuncture may be considered as a complementary treatment for anxiety in patients with Parkinson disease, especially given the limitations of conventional treatments.

Improvement in anxiety was also reflected in better motor function and overall quality of life, suggesting that treating anxiety can yield broad benefits for these patients.

It is important to consider some limitations of this study. First, all participants were Chinese, and because acupuncture is a traditional Chinese therapy widely accepted in this culture, the placebo effect observed may have been influenced by cultural factors. Future studies in more diverse populations will be needed to confirm these results. In addition, some items on the anxiety scale used may overlap with symptoms of Parkinson disease itself, which may have affected measurement accuracy.

The eight-week treatment period was also relatively short, and longer studies could provide more robust information about the durability of benefits. Despite these limitations, this was the first rigorously controlled study to demonstrate that acupuncture can effectively reduce anxiety in patients with Parkinson disease, offering hope for a more holistic and integrated therapeutic approach for this complex condition.

Strengths

  • 1First double-blind study on acupuncture for anxiety in Parkinson disease
  • 2Use of an innovative patented sham-acupuncture device
  • 3Assessment of biomarkers (ACTH) to explain mechanisms
  • 42-month follow-up showing durable effects
  • 5Publication in a high-impact journal
⚠️

Limitations

  • 1Small sample (64 participants)
  • 2Only Chinese participants - possible cultural bias
  • 3The HAM-A scale may not be ideal for anxiety in Parkinson disease
  • 4Short intervention duration
  • 5Lack of cost-effectiveness data
Dr. Marcus Yu Bin Pai

Expert Commentary

Dr. Marcus Yu Bin Pai

MD, PhD · Pain Medicine · Physical Medicine and Rehabilitation · Medical Acupuncture

Clinical Relevance

Anxiety in Parkinson disease is chronically underestimated in everyday clinical management, despite affecting approximately 31% of this population and accelerating the progression of motor symptoms. The practical problem is that the conventional armamentarium is limited: benzodiazepine anxiolytics are poorly tolerated in patients with Parkinson disease because of the risk of sedation and falls, and cognitive behavioral therapy faces problematic cost and adherence. This randomized, double-blind trial, published in JAMA Network Open, positions acupuncture as a concretely viable alternative for this niche. The patient profile that benefits most is the patient with stable Parkinson disease on optimized dopaminergic therapy but with residual anxiety interfering with gait and resting tremor — a situation any movement-disorders clinic knows well. The documented safety, with only four mild adverse events in 64 patients, reinforces the feasibility of integrating acupuncture into the multidisciplinary protocol for these cases without the risk of relevant drug interactions.

Notable Findings

The most intriguing finding of this trial is not in the immediate eight-week outcome — where both groups improved comparably on the HAM-A — but in the two-month follow-up after treatment ended. At that point, the true-acupuncture group showed a 7.03-point greater reduction on the HAM-A compared with the placebo group, with 86.8% of patients achieving clinically meaningful improvement versus only 6.4% in the control arm. This delayed-response kinetic, in which the real effect separates from placebo over time, is biologically plausible and is supported by the reduction in ACTH levels documented in the active group — suggesting modulation of the hypothalamic-pituitary-adrenal axis as the underlying mechanism. The fact that this neuroendocrine modulation parallels improvement on motor and quality-of-life scales reinforces the hypothesis that anxiety and Parkinson motor symptoms share common pathways that acupuncture can influence simultaneously.

From My Experience

In my practice in rehabilitation and pain medicine, I have increasingly received patients with Parkinson disease referred from neurology specifically for the management of non-motor symptoms, and anxiety is a frequent complaint. What this trial confirms — and what I have already observed empirically — is that the response to acupuncture in this population tends to be slow at first; I usually avoid making promises before four or five sessions, but the effect consolidates and persists. I typically work with protocols of eight to twelve sessions in the acute phase, followed by biweekly or monthly maintenance, especially when there is an associated autonomic component. I systematically combine this with guidance on adapted physical activity, because aerobic exercise has its own anxiolytic effect in Parkinson disease and appears to add to the gains from acupuncture. I avoid recommending acupuncture as the sole intervention when there is a severe anticipatory anxiety component with marked functional impairment — in those cases I prefer to optimize pharmacotherapy with the neurologist first. The profile that responds best, in my observation, is the patient with mild-to-moderate Parkinson disease, moderate-intensity anxiety, and good adherence to in-person treatment.

PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture.

Full original article

Read the full scientific study

JAMA Network Open · 2022

DOI: 10.1001/jamanetworkopen.2022.32133

Access original article

Scientific Review

Marcus Yu Bin Pai, MD, PhD

Marcus Yu Bin Pai, MD, PhD

CRM-SP: 158074 | RQE: 65523 · 65524 · 655241

PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture. Scientific review and curation of every entry in this library.

Learn more about the author →
⚕️

Medical disclaimer: This content is for educational purposes only and does not replace consultation, diagnosis, or treatment by a qualified professional. Some information may be assisted by artificial intelligence and is subject to inaccuracies. Always consult a physician.

Content reviewed by the medical team at CEIMEC — Integrated Centre for Chinese Medicine Studies, a reference in Medical Acupuncture for over 30 years.